← Back to Discover
BRAIDWELL LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $2,703,471,368
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CARIS LIFE SCIENCES INC · COM · 142152107 · shares: $147,122,490
- HINGE HEALTH INC · CL A · 433313103 · shares: $110,400,541
- GLAUKOS CORP · COM · 377322102 · shares: $82,727,718
- EDGEWISE THERAPEUTICS INC · COM · 28036F105 · shares: $81,136,688
- SPYRE THERAPEUTICS INC · COM NEW · 00773J202 · shares: $78,079,080
- IRHYTHM HOLDINGS INC · COM · 450056106 · shares: $77,824,465
- NEOGENOMICS INC · COM NEW · 64049M209 · shares: $71,756,567
- KODIAK SCIENCES INC · COM · 50015M109 · shares: $69,633,909
- XENON PHARMACEUTICALS INC · COM · 98420N105 · shares: $68,294,443
- ALPHATEC HLDGS INC · NOTE 0.750% 3/1 · 02081GAD4 · principal: $66,183,358
Reported holdings
86 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CARIS LIFE SCIENCES INC | COM | 142152107 | — | 8,256,032 shares | $147,122,490 |
| HINGE HEALTH INC | CL A | 433313103 | — | 1,330,127 shares | $110,400,541 |
| GLAUKOS CORP | COM | 377322102 | — | 591,927 shares | $82,727,718 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 1,996,965 shares | $81,136,688 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 879,467 shares | $78,079,080 |
| IRHYTHM HOLDINGS INC | COM | 450056106 | — | 654,262 shares | $77,824,465 |
| NEOGENOMICS INC | COM NEW | 64049M209 | — | 4,918,202 shares | $71,756,567 |
| KODIAK SCIENCES INC | COM | 50015M109 | — | 1,787,318 shares | $69,633,909 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 1,131,452 shares | $68,294,443 |
| ALPHATEC HLDGS INC | NOTE 0.750% 3/1 | 02081GAD4 | — | 69,121,000 principal | $66,183,358 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 2,451,562 shares | $59,327,800 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 594,562 shares | $57,957,904 |
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | — | 336,171 shares | $56,656,579 |
| ALPHATEC HLDGS INC | COM NEW | 02081G201 | — | 6,531,439 shares | $56,496,947 |
| GENERATE BIOMEDICINES INC | COM SHS | 370920100 | — | 3,283,844 shares | $55,398,448 |
| MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | — | 8,702,921 shares | $54,306,227 |
| KRYSTAL BIOTECH INC | COM | 501147102 | — | 128,975 shares | $47,936,138 |
| HUMANA INC | COM | 444859102 | — | 114,500 shares | $45,481,690 |
| THERMO FISHER SCIENTIFIC INC | COM | 883556102 | — | 89,395 shares | $44,819,077 |
| KYMERA THERAPEUTICS INC | COM | 501575104 | — | 378,163 shares | $43,363,951 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 381,128 shares | $42,316,642 |
| DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | — | 1,620,377 shares | $42,146,006 |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | — | 1,646,399 shares | $41,653,895 |
| BRIGHTSPRING HEALTH SVCS INC | COM | 10950A106 | — | 596,753 shares | $41,617,554 |
| TRANSMEDICS GROUP INC | COM | 89377M109 | — | 609,715 shares | $40,497,270 |
| MBX BIOSCIENCES INC | COM | 55287L101 | — | 710,880 shares | $39,240,576 |
| CLIMB BIO INC | COM | 28658R106 | — | 2,797,375 shares | $36,477,770 |
| CAREDX INC | COM | 14167L103 | — | 1,220,602 shares | $34,787,157 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 1,140,040 shares | $34,018,794 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 483,822 shares | $33,964,304 |
| ACADIA HEALTHCARE COMPANY IN | COM | 00404A109 | — | 1,141,477 shares | $33,707,816 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 473,617 shares | $33,063,203 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 2,126,298 shares | $31,766,892 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 1,286,769 shares | $31,217,016 |
| INSPIRE MED SYS INC | COM | 457730109 | — | 677,570 shares | $30,226,398 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 1,629,182 shares | $30,107,283 |
| ALAMAR BIOSCIENCES INC | COMMON STOCK | 010911105 | — | 1,083,983 shares | $29,365,099 |
| DANAHER CORP DEL | COM | 235851102 | — | 150,627 shares | $28,691,431 |
| INTUITIVE SURGICAL INC | COM NEW | 46120E602 | — | 70,137 shares | $27,892,082 |
| ORUKA THERAPEUTICS INC | COM | 687604108 | — | 278,164 shares | $26,472,868 |
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 801,395 shares | $26,381,923 |
| AVEANNA HEALTHCARE HLDGS INC | COM | 05356F105 | — | 3,065,106 shares | $26,267,958 |
| BIOAGE LABS INC | COM | 09077V100 | — | 1,033,129 shares | $25,321,992 |
| BOSTON SCIENTIFIC CORP | COM | 101137107 | — | 587,567 shares | $25,077,360 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 564,724 shares | $24,232,307 |
| REPLIGEN CORP | COM | 759916109 | — | 177,100 shares | $24,163,524 |
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | — | 3,980,295 shares | $23,483,741 |
| GUARDANT HEALTH INC | COM | 40131M109 | — | 147,850 shares | $22,181,936 |
| EVOLUS INC | COM | 30052C107 | — | 3,155,209 shares | $21,897,150 |
| NATERA INC | COM | 632307104 | — | 79,500 shares | $21,580,275 |
| ORTHOPEDIATRICS CORP | COM | 68752L100 | — | 1,100,370 shares | $21,050,078 |
| ELEVANCE HEALTH INC FORMERLY | COM | 036752103 | — | 53,960 shares | $20,867,951 |
| TECTONIC THERAPEUTIC INC | COM | 878972108 | — | 596,900 shares | $20,518,438 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 921,598 shares | $20,468,692 |
| NEOGENOMICS INC | NOTE 0.250% 1/1 | 64049MAB6 | — | 18,011,000 principal | $16,885,250 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 521,327 shares | $16,552,132 |
| REPLIGEN CORP | NOTE 1.000%12/1 | 759916AD1 | — | 16,000,000 principal | $16,445,954 |
| ARGENX SE | SPONSORED ADR | 04016X101 | — | 17,707 shares | $16,428,023 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 436,646 shares | $16,247,598 |
| OVID THERAPEUTICS INC | COM | 690469101 | — | 5,919,464 shares | $15,923,358 |
| MANNKIND CORP | COM NEW | 56400P706 | — | 3,458,429 shares | $14,732,908 |
| UNIQURE NV | SHS | N90064101 | — | 301,652 shares | $13,894,091 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 2,922,754 shares | $13,649,261 |
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | — | 1,214,540 shares | $13,153,468 |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | — | 183,822 shares | $11,755,417 |
| OCULIS HOLDING AG | ORDINARY SHARES | H5870P102 | — | 834,183 shares | $11,570,118 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 2,142,348 shares | $11,333,021 |
| SEAPORT THERAPEUTICS INC | COMMON STOCK | 81221K108 | — | 500,000 shares | $10,860,000 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 573,104 shares | $10,550,845 |
| SURROZEN INC | COM NEW | 86889P208 | — | 390,753 shares | $10,140,040 |
| IMMUNIC INC | COM NEW | 4525EP200 | — | 645,010 shares | $9,913,804 |
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | G4444S107 | — | 900,000 shares | $9,540,000 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 116,762 shares | $9,258,059 |
| QUEST DIAGNOSTICS INC | COM | 74834L100 | — | 43,200 shares | $9,156,240 |
| ADLAI NORTYE LTD | SPONSORED ADS | 00704R109 | — | 795,214 shares | $9,144,961 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 584,412 shares | $8,503,195 |
| KARDIGAN INC | COM | 485925101 | — | 300,000 shares | $7,155,000 |
| AMANAT ACQUISITION CORP | CL A ORD | G0375M101 | — | 700,000 shares | $7,112,000 |
| HEMAB THERAPEUTICS HLDGS INC | COM SHS | 423494103 | — | 160,000 shares | $5,876,800 |
| GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | — | 207,240 shares | $5,570,611 |
| WATERS CORP | COM | 941848103 | — | 14,040 shares | $5,265,562 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 400,000 shares | $4,280,000 |
| JATT II ACQUISITION CORP | ORD SHS | G50765109 | — | 250,000 shares | $2,840,000 |
| PULMONX CORP | COM | 745848101 | — | 752,541 shares | $978,303 |
| VYNE THERAPEUTICS INC | COM | 92941V308 | — | 916,077 shares | $596,091 |
| CYCLERION THERAPEUTICS INC | COM | 23255M204 | — | 156,890 shares | $531,857 |